Payment Breakdown by Category
Payments by Nature
| Nature of Payment | Amount | Transactions | Share |
|---|---|---|---|
| Education | $273.94 | 3 | 63.3% |
| Food and Beverage | $158.95 | 2 | 36.7% |
Top Paying Companies
| Company | Total | Records | Latest Year |
|---|---|---|---|
| JAZZ PHARMACEUTICALS INC. | $143.43 | 1 | $0 (2024) |
| Astellas Pharma US Inc | $98.00 | 1 | $0 (2024) |
| Incyte Corporation | $90.95 | 1 | $0 (2024) |
| Janssen Biotech, Inc. | $84.99 | 1 | $0 (2023) |
| E.R. Squibb & Sons, L.L.C. | $15.52 | 1 | $0 (2023) |
Payment History by Year
| Year | Amount | Transactions | Top Company |
|---|---|---|---|
| 2024 | $332.38 | 3 | JAZZ PHARMACEUTICALS INC. ($143.43) |
| 2023 | $100.51 | 2 | Janssen Biotech, Inc. ($84.99) |
All Payment Transactions
5 individual payment records from CMS Open Payments
| Date | Company | Product | Nature | Form | Amount | Type |
|---|---|---|---|---|---|---|
| 12/06/2024 | JAZZ PHARMACEUTICALS INC. | RYLAZE (Drug) | Food and Beverage | In-kind items and services | $143.43 | General |
| Category: HEMATOLOGY/ONCOLOGY | ||||||
| 05/03/2024 | Incyte Corporation | — | Education | Cash or cash equivalent | $90.95 | General |
| 03/15/2024 | Astellas Pharma US Inc | — | Education | In-kind items and services | $98.00 | General |
| 09/29/2023 | Janssen Biotech, Inc. | RYBREVANT (Drug) | Education | In-kind items and services | $84.99 | General |
| Category: Oncology | ||||||
| 06/06/2023 | E.R. Squibb & Sons, L.L.C. | ELIQUIS (Drug) | Food and Beverage | Cash or cash equivalent | $15.52 | General |
| Category: Cardiovascular | ||||||
About Dr. Veronica Guerra, MD
Dr. Veronica Guerra, MD is a Hematology & Oncology healthcare provider based in Saint Louis, Missouri. This provider has been registered with the National Plan and Provider Enumeration System (NPPES) since 09/11/2018. The National Provider Identifier (NPI) number assigned to this provider is 1326521899.
According to the Centers for Medicare & Medicaid Services (CMS) Open Payments database, Dr. Veronica Guerra, MD has received a total of $432.89 in payments from pharmaceutical and medical device companies, with $332.38 received in 2024. These payments were reported across 5 transactions from 5 companies. The most common payment nature is "Education" ($273.94).
Practice Information
- Specialty Hematology & Oncology
- Location Saint Louis, MO
- Active Since 09/11/2018
- Last Updated 06/30/2023
- Taxonomy Code 207RH0003X
- Entity Type Individual
- Practice Solo Practitioner
- NPI Number 1326521899
Products in Payments
- RYLAZE (Drug) $143.43
- RYBREVANT (Drug) $84.99
- ELIQUIS (Drug) $15.52
Explore
Data Sources
Provider data from NPPES. Payment data from CMS Open Payments. Medicare data from CMS Medicare Provider Utilization. All data is public and updated periodically.
Hematology & Oncology Doctors in Saint Louis
Maurice Willis, Md, MD
Hematology & Oncology — Payments: $77,431
Dr. Geoffrey Uy, Md, MD
Hematology & Oncology — Payments: $29,892
Dr. Jason Li, Md, MD
Hematology & Oncology — Payments: $22,919
John Finnie, Md, MD
Hematology & Oncology — Payments: $17,276
Dr. Atif Shafqat, M.d, M.D
Hematology & Oncology — Payments: $13,313
Dr. Shabbir Safdar, M.d, M.D
Hematology & Oncology — Payments: $12,290